However, there was no statistical correlation between serum PGD2 concentration and Ann Arbor stage, double expression, therapeutic efficacy and other clinical parameters in DLBCL patients (Supplementary Table 2), which required further large-sample exploration. The gene discussed is HPGDS; the disease is diffuse large B-cell lymphoma.